Levonorgestrel and ethinyl estradiol and Levothyroxine and liothyronine interaction
Levonorgestrel and ethinyl estradiol and Levothyroxine and liothyronine: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Levonorgestrel and ethinyl estradiol (Tyblume) label · effective 2026-08-27
The dose of replacement thyroid hormone or cortisol therapy may need to be increased.
Thyroid Hormone Replacement Therapy or Corticosteroid Replacement Therapy Clinical effect Concomitant use of CHCs with thyroid hormone replacement therapy or corticosteroid replacement therapy may increase systemic exposure of thyroid-binding and cortisol-binding globulin [see Warnings and Precautions (5.11) ].
Prevention or management The dose of replacement thyroid hormone or cortisol therapy may need to be increased.
From the Levothyroxine and liothyronine (NP Thyroid 60) label · effective 2026-01-01
Estrogen, Oral Contraceptives — Estrogens tend to increase serum thyroxine-binding globulin (TBg).
In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.
Therefore, patients without a functioning thyroid gland who are on thyroid replacement therapy may need to increase their thyroid dose if estrogens or estrogen-containing oral contraceptives are given.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.